P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-10-16

AUTHORS

Gabriel G. Vega, Alejandro Avilés-Salas, J. Ramón Chalapud, Melisa Martinez-Paniagua, Rosana Pelayo, Héctor Mayani, Rogelio Hernandez-Pando, Otoniel Martinez-Maza, Sara Huerta-Yepez, Benjamin Bonavida, Mario I. Vega

ABSTRACT

BACKGROUND: The p38 MAPK is constitutively activated in B-NHL cell lines and regulates chemoresistance. Accordingly, we hypothesized that activated p38 MAPK may be associated with the in vivo unresponsiveness to chemotherapy in B-NHL patients. METHODS: Tissue microarrays generated from eighty untreated patients with Diffused Large B Cell Lymphoma (DLBCL) were examined by immunohistochemistry for the expression of p38 and phospho p38 (p-p38) MAPK. In addition, both Bcl-2 and NF-κB expressions were determined. Kaplan Meier analysis was assessed. RESULTS: Tumor tissues expressed p38 MAPK (82 %) and p-p38 MAPK (30 %). Both p38 and p-p38 MAPK expressions correlated with the high score performance status. A significant correlation was found between the expression p-p38 and poor response to CHOP. The five year median follow-up FFS was 81 % for p38(-) and 34 % for p38(+) and for OS was 83 % for p38(-) and 47 % for p38(+). The p-p38(+) tissues expressed Bcl-2 and 90 % of p-p38(-) where Bcl-2(-). The coexpression of p-p38 and Bcl-2 correlated with pool EFS and OS. There was no correlation between the expression of p-p38 and the expression of NF-κB. CONCLUSION: The findings revealed, for the first time, that a subset of patients with DLBCL and whose tumors expressed high p-p38 MAPK responded poorly to CHOP therapy and had poor EFS and OS. The expression of p38, p-p38, Bcl2 and the ABC subtype are significant risk factors both p38 and p-p38 expressions remain independent prognostic factors. More... »

PAGES

722

Journal

TITLE

BMC Cancer

ISSUE

1

VOLUME

15

From Grant

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-015-1778-8

DOI

http://dx.doi.org/10.1186/s12885-015-1778-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034015778

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26475474


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Large B-Cell, Diffuse", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "NF-kappa B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Array Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vincristine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "p38 Mitogen-Activated Protein Kinases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Facultad de Medicina Programa de Posgrado, Doctorado en Ciencias Biom\u00e9dicas UNAM, M\u00e9xico City, DF Mexico", 
          "id": "http://www.grid.ac/institutes/grid.9486.3", 
          "name": [
            "Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico", 
            "Facultad de Medicina Programa de Posgrado, Doctorado en Ciencias Biom\u00e9dicas UNAM, M\u00e9xico City, DF Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vega", 
        "givenName": "Gabriel G.", 
        "id": "sg:person.01305571623.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305571623.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departamento de Patolog\u00eda, Instituto Nacional de Cancerolog\u00eda, SSA, M\u00e9xico City, M\u00e9xico", 
          "id": "http://www.grid.ac/institutes/grid.419167.c", 
          "name": [
            "Departamento de Patolog\u00eda, Instituto Nacional de Cancerolog\u00eda, SSA, M\u00e9xico City, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Avil\u00e9s-Salas", 
        "givenName": "Alejandro", 
        "id": "sg:person.01366302515.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366302515.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Servicio de Hematolog\u00eda, Instituto Nacional de Cancerolog\u00eda, SSA, M\u00e9xico City, M\u00e9xico", 
          "id": "http://www.grid.ac/institutes/grid.419167.c", 
          "name": [
            "Servicio de Hematolog\u00eda, Instituto Nacional de Cancerolog\u00eda, SSA, M\u00e9xico City, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chalapud", 
        "givenName": "J. Ram\u00f3n", 
        "id": "sg:person.01315276335.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315276335.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unidad de Investigaci\u00f3n M\u00e9dica en Inmunolog\u00eda e Infectolog\u00eda, CMN La Raza, IMSS, M\u00e9xico City, M\u00e9xico", 
          "id": "http://www.grid.ac/institutes/grid.419157.f", 
          "name": [
            "Unidad de Investigaci\u00f3n M\u00e9dica en Inmunolog\u00eda e Infectolog\u00eda, CMN La Raza, IMSS, M\u00e9xico City, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martinez-Paniagua", 
        "givenName": "Melisa", 
        "id": "sg:person.010727760157.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010727760157.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.419157.f", 
          "name": [
            "Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pelayo", 
        "givenName": "Rosana", 
        "id": "sg:person.01130353732.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130353732.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.419157.f", 
          "name": [
            "Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mayani", 
        "givenName": "H\u00e9ctor", 
        "id": "sg:person.01365471073.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365471073.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departamento de Patolog\u00eda Experimental, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n, Salvador Zubiran, SSA, M\u00e9xico City, M\u00e9xico", 
          "id": "http://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Departamento de Patolog\u00eda Experimental, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n, Salvador Zubiran, SSA, M\u00e9xico City, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hernandez-Pando", 
        "givenName": "Rogelio", 
        "id": "sg:person.01176732673.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176732673.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martinez-Maza", 
        "givenName": "Otoniel", 
        "id": "sg:person.0712176266.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712176266.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unidad de Investigaci\u00f3n en Enfermedades Oncol\u00f3gicas, Hospital Infantil de M\u00e9xico, Federico G\u00f3mez, SSA, M\u00e9xico City, M\u00e9xico", 
          "id": "http://www.grid.ac/institutes/grid.414757.4", 
          "name": [
            "Unidad de Investigaci\u00f3n en Enfermedades Oncol\u00f3gicas, Hospital Infantil de M\u00e9xico, Federico G\u00f3mez, SSA, M\u00e9xico City, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huerta-Yepez", 
        "givenName": "Sara", 
        "id": "sg:person.01171343223.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171343223.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonavida", 
        "givenName": "Benjamin", 
        "id": "sg:person.014442031637.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014442031637.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico", 
            "Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vega", 
        "givenName": "Mario I.", 
        "id": "sg:person.01123230023.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123230023.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrc2694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046607600", 
          "https://doi.org/10.1038/nrc2694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023859807", 
          "https://doi.org/10.1038/ni748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1022586318678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037491643", 
          "https://doi.org/10.1023/a:1022586318678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-13150-4_11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013219060", 
          "https://doi.org/10.1007/978-3-319-13150-4_11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02982645", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011206446", 
          "https://doi.org/10.1007/bf02982645"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12308-009-0049-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032780961", 
          "https://doi.org/10.1007/s12308-009-0049-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011264195", 
          "https://doi.org/10.1038/sj.onc.1207336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2008.92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014261486", 
          "https://doi.org/10.1038/bmt.2008.92"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-12-478", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000231171", 
          "https://doi.org/10.1186/1471-2407-12-478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng2037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050222108", 
          "https://doi.org/10.1038/ng2037"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-10-16", 
    "datePublishedReg": "2015-10-16", 
    "description": "BACKGROUND: The p38 MAPK is constitutively activated in B-NHL cell lines and regulates chemoresistance. Accordingly, we hypothesized that activated p38 MAPK may be associated with the in vivo unresponsiveness to chemotherapy in B-NHL patients.\nMETHODS: Tissue microarrays generated from eighty untreated patients with Diffused Large B Cell Lymphoma (DLBCL) were examined by immunohistochemistry for the expression of p38 and phospho p38 (p-p38) MAPK. In addition, both Bcl-2 and NF-\u03baB expressions were determined. Kaplan Meier analysis was assessed.\nRESULTS: Tumor tissues expressed p38 MAPK (82 %) and p-p38 MAPK (30 %). Both p38 and p-p38 MAPK expressions correlated with the high score performance status. A significant correlation was found between the expression p-p38 and poor response to CHOP. The five year median follow-up FFS was 81 % for p38(-) and 34 % for p38(+) and for OS was 83 % for p38(-) and 47 % for p38(+). The p-p38(+) tissues expressed Bcl-2 and 90 % of p-p38(-) where Bcl-2(-). The coexpression of p-p38 and Bcl-2 correlated with pool EFS and OS. There was no correlation between the expression of p-p38 and the expression of NF-\u03baB.\nCONCLUSION: The findings revealed, for the first time, that a subset of patients with DLBCL and whose tumors expressed high p-p38 MAPK responded poorly to CHOP therapy and had poor EFS and OS. The expression of p38, p-p38, Bcl2 and the ABC subtype are significant risk factors both p38 and p-p38 expressions remain independent prognostic factors.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12885-015-1778-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2354610", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "p38 MAPK expression", 
      "expression of p38", 
      "p38 MAPK", 
      "cell lymphoma", 
      "Bcl-2", 
      "MAPK expression", 
      "years median follow", 
      "subset of patients", 
      "independent prognostic factor", 
      "Kaplan-Meier analysis", 
      "NF-\u03baB expression", 
      "significant risk factors", 
      "failure of response", 
      "expression of NF", 
      "Diffuse Large B", 
      "NHL cell lines", 
      "phospho-p38 MAPK", 
      "poor EFS", 
      "median follow", 
      "untreated patients", 
      "performance status", 
      "NHL patients", 
      "prognostic factors", 
      "Meier analysis", 
      "risk factors", 
      "poor response", 
      "tissue microarray", 
      "ABC subtype", 
      "p38 expression", 
      "Large B", 
      "patients", 
      "tumor tissue", 
      "significant correlation", 
      "cell lines", 
      "lymphoma", 
      "p38", 
      "MAPK", 
      "CHOP", 
      "expression", 
      "OS", 
      "tissue", 
      "chemotherapy", 
      "therapy", 
      "immunohistochemistry", 
      "follow", 
      "DLBCL", 
      "tumors", 
      "EFS", 
      "chemoresistance", 
      "subtypes", 
      "response", 
      "BCL2", 
      "factors", 
      "expression p", 
      "vivo", 
      "activation", 
      "correlation", 
      "status", 
      "NF", 
      "coexpression", 
      "FFS", 
      "failure", 
      "microarrays", 
      "findings", 
      "subset", 
      "first time", 
      "EF", 
      "addition", 
      "lines", 
      "time", 
      "analysis", 
      "high score performance status", 
      "score performance status", 
      "pool EFS"
    ], 
    "name": "P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma", 
    "pagination": "722", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034015778"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-015-1778-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26475474"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-015-1778-8", 
      "https://app.dimensions.ai/details/publication/pub.1034015778"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_673.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12885-015-1778-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1778-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1778-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1778-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1778-8'


 

This table displays all metadata directly associated to this object as RDF triples.

356 TRIPLES      22 PREDICATES      132 URIs      114 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-015-1778-8 schema:about N0036bf1adcfb4de795315a2b2d0d774d
2 N1f78b0bba75246aea8f795cbb5afd9fe
3 N25a65ddc841147478f85f524be94f2f9
4 N32cc9f479c3e45019b7d3c816c097767
5 N385c26fdad4e4c95a80bfc20a3d2a9d8
6 N3cc644587c524f69878e2aab0b28ad1d
7 N700ac222a29b422da50aba272470ad4d
8 N734367944f714df5a116b51ec20a3b2b
9 N73e1732d2c00494ea42262997f4b096a
10 N7f2e70a1900740149dc22adf469633f2
11 N907f37f522f541b1a223e086ab31d886
12 N976d2301d46e45ad9706117634950e97
13 N9ac9fa83ace24ca99060043e9d82bdd3
14 Na9a93ef37f1947bdb3786954dd0b7f04
15 Nabdb520e55874f8d9b4d34d71385302e
16 Nad115e8926364e27b57e33b995a5072d
17 Nb0a218245eea4b3da5c47574a891fc1a
18 Nd3926dee86ef4c2bb717cbfb7cfb4fd4
19 Ne3f006c96836421b90cd262aca0a4530
20 Nefb0a070e9a84446a1036253db3bc237
21 Nf9d93e815e7644aab7b17e539e723b9f
22 Nfeb40cdb538140b8b94c3de98a147562
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author N27e56a1475244828a666dcd311890b41
26 schema:citation sg:pub.10.1007/978-3-319-13150-4_11
27 sg:pub.10.1007/bf02982645
28 sg:pub.10.1007/s12308-009-0049-5
29 sg:pub.10.1023/a:1022586318678
30 sg:pub.10.1038/bmt.2008.92
31 sg:pub.10.1038/ng2037
32 sg:pub.10.1038/ni748
33 sg:pub.10.1038/nrc2694
34 sg:pub.10.1038/sj.onc.1207336
35 sg:pub.10.1186/1471-2407-12-478
36 schema:datePublished 2015-10-16
37 schema:datePublishedReg 2015-10-16
38 schema:description BACKGROUND: The p38 MAPK is constitutively activated in B-NHL cell lines and regulates chemoresistance. Accordingly, we hypothesized that activated p38 MAPK may be associated with the in vivo unresponsiveness to chemotherapy in B-NHL patients. METHODS: Tissue microarrays generated from eighty untreated patients with Diffused Large B Cell Lymphoma (DLBCL) were examined by immunohistochemistry for the expression of p38 and phospho p38 (p-p38) MAPK. In addition, both Bcl-2 and NF-κB expressions were determined. Kaplan Meier analysis was assessed. RESULTS: Tumor tissues expressed p38 MAPK (82 %) and p-p38 MAPK (30 %). Both p38 and p-p38 MAPK expressions correlated with the high score performance status. A significant correlation was found between the expression p-p38 and poor response to CHOP. The five year median follow-up FFS was 81 % for p38(-) and 34 % for p38(+) and for OS was 83 % for p38(-) and 47 % for p38(+). The p-p38(+) tissues expressed Bcl-2 and 90 % of p-p38(-) where Bcl-2(-). The coexpression of p-p38 and Bcl-2 correlated with pool EFS and OS. There was no correlation between the expression of p-p38 and the expression of NF-κB. CONCLUSION: The findings revealed, for the first time, that a subset of patients with DLBCL and whose tumors expressed high p-p38 MAPK responded poorly to CHOP therapy and had poor EFS and OS. The expression of p38, p-p38, Bcl2 and the ABC subtype are significant risk factors both p38 and p-p38 expressions remain independent prognostic factors.
39 schema:genre article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N0c29243789c2494183a187fce69ced8a
43 N24c0df1d142244e78b82146622ed90f7
44 sg:journal.1024632
45 schema:keywords ABC subtype
46 BCL2
47 Bcl-2
48 CHOP
49 DLBCL
50 Diffuse Large B
51 EF
52 EFS
53 FFS
54 Kaplan-Meier analysis
55 Large B
56 MAPK
57 MAPK expression
58 Meier analysis
59 NF
60 NF-κB expression
61 NHL cell lines
62 NHL patients
63 OS
64 activation
65 addition
66 analysis
67 cell lines
68 cell lymphoma
69 chemoresistance
70 chemotherapy
71 coexpression
72 correlation
73 expression
74 expression of NF
75 expression of p38
76 expression p
77 factors
78 failure
79 failure of response
80 findings
81 first time
82 follow
83 high score performance status
84 immunohistochemistry
85 independent prognostic factor
86 lines
87 lymphoma
88 median follow
89 microarrays
90 p38
91 p38 MAPK
92 p38 MAPK expression
93 p38 expression
94 patients
95 performance status
96 phospho-p38 MAPK
97 pool EFS
98 poor EFS
99 poor response
100 prognostic factors
101 response
102 risk factors
103 score performance status
104 significant correlation
105 significant risk factors
106 status
107 subset
108 subset of patients
109 subtypes
110 therapy
111 time
112 tissue
113 tissue microarray
114 tumor tissue
115 tumors
116 untreated patients
117 vivo
118 years median follow
119 schema:name P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma
120 schema:pagination 722
121 schema:productId N546d00e69e6a4288add01d7fc6e699a8
122 N62fe1ec9f28946e68b1232175da3f13d
123 Ndbc60f178eca45e4afc4d1e6200c3ad8
124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034015778
125 https://doi.org/10.1186/s12885-015-1778-8
126 schema:sdDatePublished 2021-12-01T19:33
127 schema:sdLicense https://scigraph.springernature.com/explorer/license/
128 schema:sdPublisher N31164d075c0840fbb99fd565567260e4
129 schema:url https://doi.org/10.1186/s12885-015-1778-8
130 sgo:license sg:explorer/license/
131 sgo:sdDataset articles
132 rdf:type schema:ScholarlyArticle
133 N0036bf1adcfb4de795315a2b2d0d774d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Disease-Free Survival
135 rdf:type schema:DefinedTerm
136 N0c29243789c2494183a187fce69ced8a schema:volumeNumber 15
137 rdf:type schema:PublicationVolume
138 N1f78b0bba75246aea8f795cbb5afd9fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 N22b2c28e389940f2ba9b24f862604161 rdf:first sg:person.01365471073.78
142 rdf:rest N2852d5e5f121424caa3c6b8936f85b17
143 N24c0df1d142244e78b82146622ed90f7 schema:issueNumber 1
144 rdf:type schema:PublicationIssue
145 N25a65ddc841147478f85f524be94f2f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Vincristine
147 rdf:type schema:DefinedTerm
148 N27e56a1475244828a666dcd311890b41 rdf:first sg:person.01305571623.01
149 rdf:rest N9cd7c5c1c0714ab995265f04997877d8
150 N2852d5e5f121424caa3c6b8936f85b17 rdf:first sg:person.01176732673.47
151 rdf:rest N90aab71a4a5d42f6858c2225e9ca637f
152 N2c8d7c7a91e24da6a574b66cd33640b6 rdf:first sg:person.01123230023.51
153 rdf:rest rdf:nil
154 N31164d075c0840fbb99fd565567260e4 schema:name Springer Nature - SN SciGraph project
155 rdf:type schema:Organization
156 N32cc9f479c3e45019b7d3c816c097767 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Male
158 rdf:type schema:DefinedTerm
159 N385c26fdad4e4c95a80bfc20a3d2a9d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Prednisone
161 rdf:type schema:DefinedTerm
162 N3cc644587c524f69878e2aab0b28ad1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Lymphoma, Large B-Cell, Diffuse
164 rdf:type schema:DefinedTerm
165 N546d00e69e6a4288add01d7fc6e699a8 schema:name pubmed_id
166 schema:value 26475474
167 rdf:type schema:PropertyValue
168 N62fe1ec9f28946e68b1232175da3f13d schema:name doi
169 schema:value 10.1186/s12885-015-1778-8
170 rdf:type schema:PropertyValue
171 N700ac222a29b422da50aba272470ad4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Cyclophosphamide
173 rdf:type schema:DefinedTerm
174 N706df3efc65e476a96d5d8ae11f6e796 rdf:first sg:person.01130353732.88
175 rdf:rest N22b2c28e389940f2ba9b24f862604161
176 N7073c373108147d9afca4a10dda336c8 rdf:first sg:person.014442031637.81
177 rdf:rest N2c8d7c7a91e24da6a574b66cd33640b6
178 N734367944f714df5a116b51ec20a3b2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Proto-Oncogene Proteins c-bcl-2
180 rdf:type schema:DefinedTerm
181 N73e1732d2c00494ea42262997f4b096a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name p38 Mitogen-Activated Protein Kinases
183 rdf:type schema:DefinedTerm
184 N7f2e70a1900740149dc22adf469633f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Kaplan-Meier Estimate
186 rdf:type schema:DefinedTerm
187 N907f37f522f541b1a223e086ab31d886 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Antineoplastic Combined Chemotherapy Protocols
189 rdf:type schema:DefinedTerm
190 N90aab71a4a5d42f6858c2225e9ca637f rdf:first sg:person.0712176266.14
191 rdf:rest Na6932ca0e83d4b2eb41fcff1a3ad7075
192 N976d2301d46e45ad9706117634950e97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Middle Aged
194 rdf:type schema:DefinedTerm
195 N98cc4e2fab18466a840543c4645e5b70 rdf:first sg:person.010727760157.20
196 rdf:rest N706df3efc65e476a96d5d8ae11f6e796
197 N9ac9fa83ace24ca99060043e9d82bdd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Doxorubicin
199 rdf:type schema:DefinedTerm
200 N9cd7c5c1c0714ab995265f04997877d8 rdf:first sg:person.01366302515.33
201 rdf:rest Nf87297e9e2a04f76be8b0d04eb1e3f40
202 Na6932ca0e83d4b2eb41fcff1a3ad7075 rdf:first sg:person.01171343223.95
203 rdf:rest N7073c373108147d9afca4a10dda336c8
204 Na9a93ef37f1947bdb3786954dd0b7f04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Adult
206 rdf:type schema:DefinedTerm
207 Nabdb520e55874f8d9b4d34d71385302e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Adolescent
209 rdf:type schema:DefinedTerm
210 Nad115e8926364e27b57e33b995a5072d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Tissue Array Analysis
212 rdf:type schema:DefinedTerm
213 Nb0a218245eea4b3da5c47574a891fc1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Gene Expression Regulation, Neoplastic
215 rdf:type schema:DefinedTerm
216 Nd3926dee86ef4c2bb717cbfb7cfb4fd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name NF-kappa B
218 rdf:type schema:DefinedTerm
219 Ndbc60f178eca45e4afc4d1e6200c3ad8 schema:name dimensions_id
220 schema:value pub.1034015778
221 rdf:type schema:PropertyValue
222 Ne3f006c96836421b90cd262aca0a4530 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Female
224 rdf:type schema:DefinedTerm
225 Nefb0a070e9a84446a1036253db3bc237 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Prognosis
227 rdf:type schema:DefinedTerm
228 Nf87297e9e2a04f76be8b0d04eb1e3f40 rdf:first sg:person.01315276335.82
229 rdf:rest N98cc4e2fab18466a840543c4645e5b70
230 Nf9d93e815e7644aab7b17e539e723b9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Aged, 80 and over
232 rdf:type schema:DefinedTerm
233 Nfeb40cdb538140b8b94c3de98a147562 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Aged
235 rdf:type schema:DefinedTerm
236 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
237 schema:name Medical and Health Sciences
238 rdf:type schema:DefinedTerm
239 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
240 schema:name Oncology and Carcinogenesis
241 rdf:type schema:DefinedTerm
242 sg:grant.2354610 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-015-1778-8
243 rdf:type schema:MonetaryGrant
244 sg:journal.1024632 schema:issn 1471-2407
245 schema:name BMC Cancer
246 schema:publisher Springer Nature
247 rdf:type schema:Periodical
248 sg:person.010727760157.20 schema:affiliation grid-institutes:grid.419157.f
249 schema:familyName Martinez-Paniagua
250 schema:givenName Melisa
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010727760157.20
252 rdf:type schema:Person
253 sg:person.01123230023.51 schema:affiliation grid-institutes:grid.19006.3e
254 schema:familyName Vega
255 schema:givenName Mario I.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123230023.51
257 rdf:type schema:Person
258 sg:person.01130353732.88 schema:affiliation grid-institutes:grid.419157.f
259 schema:familyName Pelayo
260 schema:givenName Rosana
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130353732.88
262 rdf:type schema:Person
263 sg:person.01171343223.95 schema:affiliation grid-institutes:grid.414757.4
264 schema:familyName Huerta-Yepez
265 schema:givenName Sara
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171343223.95
267 rdf:type schema:Person
268 sg:person.01176732673.47 schema:affiliation grid-institutes:grid.416850.e
269 schema:familyName Hernandez-Pando
270 schema:givenName Rogelio
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176732673.47
272 rdf:type schema:Person
273 sg:person.01305571623.01 schema:affiliation grid-institutes:grid.9486.3
274 schema:familyName Vega
275 schema:givenName Gabriel G.
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305571623.01
277 rdf:type schema:Person
278 sg:person.01315276335.82 schema:affiliation grid-institutes:grid.419167.c
279 schema:familyName Chalapud
280 schema:givenName J. Ramón
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315276335.82
282 rdf:type schema:Person
283 sg:person.01365471073.78 schema:affiliation grid-institutes:grid.419157.f
284 schema:familyName Mayani
285 schema:givenName Héctor
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365471073.78
287 rdf:type schema:Person
288 sg:person.01366302515.33 schema:affiliation grid-institutes:grid.419167.c
289 schema:familyName Avilés-Salas
290 schema:givenName Alejandro
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366302515.33
292 rdf:type schema:Person
293 sg:person.014442031637.81 schema:affiliation grid-institutes:grid.19006.3e
294 schema:familyName Bonavida
295 schema:givenName Benjamin
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014442031637.81
297 rdf:type schema:Person
298 sg:person.0712176266.14 schema:affiliation grid-institutes:grid.19006.3e
299 schema:familyName Martinez-Maza
300 schema:givenName Otoniel
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712176266.14
302 rdf:type schema:Person
303 sg:pub.10.1007/978-3-319-13150-4_11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013219060
304 https://doi.org/10.1007/978-3-319-13150-4_11
305 rdf:type schema:CreativeWork
306 sg:pub.10.1007/bf02982645 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011206446
307 https://doi.org/10.1007/bf02982645
308 rdf:type schema:CreativeWork
309 sg:pub.10.1007/s12308-009-0049-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032780961
310 https://doi.org/10.1007/s12308-009-0049-5
311 rdf:type schema:CreativeWork
312 sg:pub.10.1023/a:1022586318678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037491643
313 https://doi.org/10.1023/a:1022586318678
314 rdf:type schema:CreativeWork
315 sg:pub.10.1038/bmt.2008.92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014261486
316 https://doi.org/10.1038/bmt.2008.92
317 rdf:type schema:CreativeWork
318 sg:pub.10.1038/ng2037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050222108
319 https://doi.org/10.1038/ng2037
320 rdf:type schema:CreativeWork
321 sg:pub.10.1038/ni748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023859807
322 https://doi.org/10.1038/ni748
323 rdf:type schema:CreativeWork
324 sg:pub.10.1038/nrc2694 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046607600
325 https://doi.org/10.1038/nrc2694
326 rdf:type schema:CreativeWork
327 sg:pub.10.1038/sj.onc.1207336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011264195
328 https://doi.org/10.1038/sj.onc.1207336
329 rdf:type schema:CreativeWork
330 sg:pub.10.1186/1471-2407-12-478 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000231171
331 https://doi.org/10.1186/1471-2407-12-478
332 rdf:type schema:CreativeWork
333 grid-institutes:grid.19006.3e schema:alternateName Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA
334 schema:name Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine UCLA, Los Angeles, CA USA
335 Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico
336 rdf:type schema:Organization
337 grid-institutes:grid.414757.4 schema:alternateName Unidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México, Federico Gómez, SSA, México City, México
338 schema:name Unidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México, Federico Gómez, SSA, México City, México
339 rdf:type schema:Organization
340 grid-institutes:grid.416850.e schema:alternateName Departamento de Patología Experimental, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, SSA, México City, México
341 schema:name Departamento de Patología Experimental, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, SSA, México City, México
342 rdf:type schema:Organization
343 grid-institutes:grid.419157.f schema:alternateName Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico
344 Unidad de Investigación Médica en Inmunología e Infectología, CMN La Raza, IMSS, México City, México
345 schema:name Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico
346 Unidad de Investigación Médica en Inmunología e Infectología, CMN La Raza, IMSS, México City, México
347 rdf:type schema:Organization
348 grid-institutes:grid.419167.c schema:alternateName Departamento de Patología, Instituto Nacional de Cancerología, SSA, México City, México
349 Servicio de Hematología, Instituto Nacional de Cancerología, SSA, México City, México
350 schema:name Departamento de Patología, Instituto Nacional de Cancerología, SSA, México City, México
351 Servicio de Hematología, Instituto Nacional de Cancerología, SSA, México City, México
352 rdf:type schema:Organization
353 grid-institutes:grid.9486.3 schema:alternateName Facultad de Medicina Programa de Posgrado, Doctorado en Ciencias Biomédicas UNAM, México City, DF Mexico
354 schema:name Facultad de Medicina Programa de Posgrado, Doctorado en Ciencias Biomédicas UNAM, México City, DF Mexico
355 Oncology Research Unit, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico
356 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...